The World Health Organization recognizes medication related errors as major threat, focusing at 5 particular moments. This including the time when prescribing and administrating medication, as well when there is addition, review and stopping of medication.
To reduce medication harm, the rapid advancement of artificial intelligence (AI) shows its potential to assist clinical team with its ability to navigate and analyze vast amount of clinical, genomic, metabolomics and environmental data during the busy clinical setting.
We have witnessed continuous enhancement of Clinical Management System (CMS), including the latest reminder to help clinician in reminding clinical intention and target INR for anticoagulant as to minimize risk incurred from inadvertent suspension of medication or erroneous dosing. This marks an important step in applying technology to reduce medication errors starting with high risk medications.
In recognizing the rapidly advancement in applying genomic medicine for medication safety, an initial action taken locally is the preemptive alert of HLA status before initiation of medication such as carbamazepine and allopurinol. It is envisaged more general application of precision medicine in future.
The decision of treat and treatment target is followed by decision on dosing regimen. Effective communication of these important decisions to other clinical team members and patient is of utmost importance in medication safety. Standardization of complex regimen and reminder of the at finger tips of patients via HA GO greatly empower our patients. The real time tracking of relevant laboratory results will also further reduce error during medication administration.
We believe the application of AI will help improve quality of care while the health care team to grow along with the technology. Instead of replacing health care professional, it will allow us to leave more time for human touch, and do their job better.
